Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
McKesson

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Details for Patent: 6,916,802


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,916,802 protect, and when does it expire?

Patent 6,916,802 protects CERDELGA and is included in one NDA.

This patent has eleven patent family members in seven countries.

Summary for Patent: 6,916,802
Title: Amino ceramide-like compounds and therapeutic methods of use
Abstract:The present invention provides amino ceramide-like compounds which inhibit glucosyl ceramide (GlyCer) formation by inhibiting the enzyme GlyCer synthase, thereby lowering the level of glycosphingolipids. The compounds of the present invention have improved GlcCer synthase inhibition activity and are therefore useful in therapeutic methods for treating various conditions and diseases associated with altered glycosphingolipid levels.
Inventor(s): Shayman; James A. (Ann Arbor, MI), Harris; David J. (Lexington, MA), Siegel; Craig (Woburn, MA), Nelson; Carol A. (Westford, MA), Copeland; Diane P. (North Billerica, MA)
Assignee: Genzyme Corporation (Cambridge, MA) The Regents of the University of Michigan (Ann Arbor, MI)
Application Number:10/839,497
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,916,802
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 6,916,802

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genzyme Corp CERDELGA eliglustat tartrate CAPSULE;ORAL 205494-001 Aug 19, 2014 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y TREATMENT OF GAUCHER DISEASE TYPE 1 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
McKinsey
Colorcon
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.